ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » General Practice

Top General Practice Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TERRY HARRISON M.D.

General Practice

35,509

$1.62M

1106
796 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

27%
patients receiving schedule three controlled substances

Avg: 24%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $51

VOLKER WINKLER MD

General Practice

23,788

$1.32M

870
405 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

29%
patients receiving schedule three controlled substances

Avg: 24%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $51

PHILIP NEWTON MD

General Practice

20,535

$1.01M

392
358 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

29%
patients receiving schedule three controlled substances

Avg: 24%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $51

MARK JENKINS M.D.

General Practice

18,737

$724K

522
422 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 24%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $51

PETER STIMPSON M.D.

General Practice

18,268

$1.46M

574
418 are 65+

21%
patients receiving schedule two controlled substances

Avg: 9%

28%
patients receiving schedule three controlled substances

Avg: 24%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $51

THOMAS COX MD

General Practice

14,792

$967K

502
271 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

24%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $51

RAMON AQUINO M.D.

General Practice

14,071

$556K

496
228 are 65+

22%
patients receiving schedule two controlled substances

Avg: 9%

34%
patients receiving schedule three controlled substances

Avg: 24%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $51

FRANK CALHOUN MD

General Practice

14,010

$830K

666
426 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 24%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $51

MICHAEL SMITH MD

General Practice

13,245

$688K

463
267 are 65+

20%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $51

BIENVENIDO SAMSON MD

General Practice

12,147

$539K

319
200 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

36%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $51

JAMES WALL MD

General Practice

11,476

$418K

278
189 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

43%
patients receiving schedule three controlled substances

Avg: 24%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $51

RANDY FLORENDO MD

General Practice

10,540

$476K

295
174 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

34%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $51

CALVIN BRYAN M.D.

General Practice

10,397

$391K

447
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 24%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $51

LARRY TURNER M.D.

General Practice

9,580

$339K

434
304 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $51

TRUEMAN SMITH M.D.

General Practice

9,211

$448K

287
215 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 24%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $51

DONALD SPENCER MD

General Practice

8,307

$305K

243
153 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

40%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $51

ALAN COX MD

General Practice

8,063

$400K

287
141 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

29%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $51

JOHN HOLANCIN MD

General Practice

7,906

$351K

254
224 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $51

THOMAS BODUCH M.D.

General Practice

7,340

$312K

380
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 24%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $51

PATRICIA MITCHUM M.D.

General Practice

7,053

$433K

247
145 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $51

ERNEST JOHNSON M.D.

General Practice

6,498

$337K

204
156 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

28%
patients receiving schedule three controlled substances

Avg: 24%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $51

DONALD WALTERS MDPC

General Practice

6,395

$204K

295
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 24%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$32
Average prescription price

Avg: $51

MICHAEL MACQUARRIE MD

General Practice

6,357

$356K

200
134 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 24%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $51

JOHN BURRELL M.D.

General Practice

6,265

$277K

305
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $51

THOMAS KOWAL M.D.

General Practice

5,940

$263K

222
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

21%
patients receiving schedule three controlled substances

Avg: 24%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank